Insulin infusion management device, insulin infusion management system and method

Abstract

The present application relates to an insulin infusion management device, an insulin infusion management system and a method, wherein the user interface of the insulin infusion management device includes a real-time monitoring interface; the information statistics display area of ​​the real-time monitoring interface displays a blood glucose change curve generated according to the blood glucose monitoring information and the first association relationship; when the blood glucose level recording point is selected by the first user input, the information statistics display area is controlled to float and display the numerical display area, and the numerical display area is vertically connected to the selected blood glucose level recording point through a dotted indicator line, so that the numerical display area and the blood glucose change curve are fully displayed in the information statistics display area at the same time; receiving the drag operation input by the second user, and displaying the corresponding blood glucose monitoring information and / or insulin infusion information according to the association of the blood glucose level recording point. It ensures the safety and reliability of insulin infusion control and blood glucose monitoring, and improves the user experience.

Description

Technical Field

[0001] The present application relates to the field of insulin infusion control, and in particular to an insulin infusion management device, an insulin infusion management system and a method. Background Art

[0002] Diabetes is a chronic disease. It occurs when the pancreas does not produce enough insulin or the body cannot effectively use the insulin that is produced. Insulin is a hormone that regulates blood sugar. Hyperglycemia, or elevated blood sugar, is a common consequence of uncontrolled diabetes and can cause serious damage to many systems in the body, especially nerves and blood vessels, over time. Therefore, self-monitoring of blood sugar and subcutaneous insulin infusion are the typical methods used to treat diabetes. Inadequate insulin doses can lead to hyperglycemia, while excessive insulin doses can lead to hypoglycemia, and prolonged hypoglycemia can cause clumsy thinking, difficulty speaking, confusion, loss of consciousness, seizures, or death. Therefore, people with diabetes (PWD) face a considerable cognitive burden when determining the appropriate infusion dose.

[0003] At present, under the premise of complying with the doctor's advice, diabetic patients use insulin infusion devices and continuous blood glucose monitoring devices to achieve insulin infusion functions and blood glucose monitoring respectively. Existing insulin infusion devices and continuous blood glucose monitoring devices cannot provide wireless communication between system components, and cannot simultaneously display the safe operation of insulin infusion control and blood glucose monitoring, and the user experience needs to be improved. Summary of the invention

[0004] In this embodiment, an insulin infusion management device, an insulin infusion management system and an insulin infusion management method are provided.

[0005] In a first aspect, an insulin infusion management device is provided in this embodiment, comprising: a communication module and a user interface; wherein: the communication module is used to receive blood glucose monitoring information and insulin infusion information carrying time information;

[0006] The user interface includes a real-time monitoring interface;

[0007] The real-time monitoring interface includes an information statistics display area; the horizontal axis of the information statistics display area is set to be a time axis, the first vertical axis is an insulin infusion dose reference value, and the second vertical axis is a blood glucose reference value; the time information is mapped on the time axis to form a first association relationship;

[0008] The information statistics display area displays a blood sugar change curve generated according to the blood sugar monitoring information and the first association relationship; the blood sugar change curve includes a plurality of blood sugar level recording points, wherein when the blood sugar level recording point is selected by the first user input, the information statistics display area is controlled to float display a numerical display area, and the numerical display area is vertically connected to the selected blood sugar level recording point through a dotted indicator line, so that the numerical display area and the blood sugar change curve are fully displayed simultaneously in the information statistics display area;

[0009] The numerical display area is also used to receive a drag operation input by a second user, and dynamically select a blood glucose level recording point through the drag operation. The numerical display area is also used to display corresponding blood glucose monitoring information and / or insulin infusion information based on the dynamically selected blood glucose level recording point.

[0010] In some of the embodiments, the information statistics display area is also used to display a blood sugar safety zone;

[0011] The upper boundary of the blood sugar safety block corresponds to the upper limit value of the preset blood sugar safety threshold range; the lower boundary of the blood sugar safety block corresponds to the lower limit value of the preset blood sugar safety threshold range;

[0012] The blood sugar safety block is used to monitor the changing trend of the blood sugar change curve, wherein the part of the blood sugar change curve exceeding the blood sugar safety block forms an alarm curve, and the display mode of the alarm curve is different from the display mode of the blood sugar change curve.

[0013] In some of the embodiments, the user interface further includes a bolus infusion setting interface, the bolus infusion setting interface being used to set single bolus infusion information or multiple bolus infusion information at the same time in response to a third user input;

[0014] The information statistics display area is also used to display a first bar graph, which includes a first monochrome block and a first multi-color combination block. The first monochrome block is used to represent single large-dose numerical information; the first multi-color combination block is used to represent multiple large-dose infusion information at the same time.

[0015] In some of these embodiments, the user interface further comprises a basal rate infusion setting interface, the basal rate infusion setting interface being used to set regular basal rate infusion information or temporary basal rate infusion information at different times in response to a fourth user input;

[0016] The information statistics display area also includes a second bar graph, which is used to display regular basic rate information or temporary basic rate numerical information at different times; wherein, there is a partial overlapping area between the first bar graph and the second bar graph, and the first bar graph and the second bar graph are displayed separately.

[0017] In some of these embodiments, the user interface further includes an event logging interface;

[0018] The event recording interface is used to record event time and event behavior corresponding to blood glucose monitoring management in response to a fifth user input;

[0019] The information statistics display area is also used to display event identification.

[0020] In some of the embodiments, the information statistics display area displays at least one time label; the time label corresponds to a time segment on the display time axis;

[0021] The information statistics display area is also used to respond to the first user input to select the time label, and switch and display the corresponding time segment on the time axis according to the selected time label, as well as the blood sugar change curve and event identification within the corresponding time segment.

[0022] In some of the embodiments, the real-time monitoring interface also includes a real-time blood glucose display area; the real-time blood glucose display area is used to display the current blood glucose monitoring information monitored in real time; the real-time blood glucose display area is also used to generate a blood glucose abnormality prompt when the current blood glucose monitoring information exceeds the blood glucose safety threshold range.

[0023] In some embodiments, the user interface further comprises a bolus estimation interface; the bolus estimation interface comprises a blood glucose value setting area; the blood glucose value setting area is used to display a first option and a second option; the first option is used to select a dynamic continuous blood glucose monitoring value as current blood glucose monitoring information; the second option is used to select a current finger blood value as current blood glucose monitoring information;

[0024] The blood glucose value setting area is also used to respond to the sixth user input's selection operation of the first option, use the dynamic continuous blood glucose monitoring value as the current blood glucose monitoring information, and set the second option to not respond to user input operations; and, in response to the seventh user input's selection operation of the second option, use the received current finger blood value as the current blood glucose monitoring information.

[0025] In a second aspect, an insulin infusion management system is provided in this embodiment, comprising: a blood glucose monitoring device, an insulin infusion device, and the insulin infusion management device described in the first aspect above; wherein:

[0026] The blood sugar monitoring device is used to perform blood sugar monitoring to obtain blood sugar monitoring information;

[0027] The insulin infusion management device is used to receive and display the blood sugar monitoring information and insulin infusion information, and generate an infusion instruction according to the blood sugar monitoring information and insulin infusion information;

[0028] The insulin infusion device is used to receive the infusion instruction and perform insulin infusion.

[0029] In a third aspect, a method for managing insulin infusion is provided in this embodiment, the method comprising:

[0030] Receive blood glucose monitoring information and insulin infusion information with time information;

[0031] Displaying a real-time monitoring interface, the real-time monitoring interface including an information statistics display area;

[0032] The horizontal axis of the information statistics display area is set to be the time axis, the first vertical axis is the insulin infusion dose reference value, and the second vertical axis is the blood glucose reference value; the time information is mapped on the time axis to form a first association relationship;

[0033] Controlling the information statistics display area to display a blood glucose change curve generated according to the blood glucose monitoring information and the first association relationship; the blood glucose change curve includes a plurality of blood glucose level recording points, wherein when the blood glucose level recording point is selected by the first user input, controlling the information statistics display area to floatly display a numerical display area, the numerical display area being vertically connected to the selected blood glucose level recording point through a dotted indicator line, so that the numerical display area and the blood glucose change curve are fully displayed simultaneously in the information statistics display area;

[0034] A drag operation input by a second user is received, and a blood glucose level recording point is dynamically selected through the drag operation. The numerical display area is also used to display corresponding blood glucose monitoring information and / or insulin infusion information in association with the dynamically selected blood glucose level recording point.

[0035] In the present embodiment, an insulin infusion management device, an insulin infusion management system and an insulin infusion management method are provided. The insulin infusion management device provides a user interface for realizing insulin infusion control and blood glucose monitoring, which can simplify the infusion control operation of insulin, reduce the cognitive burden of the user for insulin infusion, and provide the user with a richer operation experience. In addition, the interactive user interface provided by the present embodiment highlights the operable information, thereby reducing the user's operation difficulty, so that ordinary users can quickly determine the appropriate insulin infusion action. In addition, in some cases, the insulin infusion management device of the present embodiment can adapt to the insulin infusion under different user activities such as meals, exercise, and medication, and correspondingly display the relevant events affecting blood glucose and insulin infusion. The present embodiment can also display the monitored blood glucose data in the user interface to realize the real-time monitoring of blood glucose levels. In some cases, the user interface provided by the present embodiment can also display the insulin infusion situation. In some cases, the user interface provided by the present embodiment can also present the use status and maintenance information of the associated blood glucose monitoring device and insulin infusion device to notify the user to carry out equipment maintenance activities and detected system problems that need to be maintained in time. Therefore, the insulin infusion management device provided in this embodiment can ensure the safety and reliability of insulin infusion control and blood glucose monitoring from different dimensions such as insulin infusion control, infusion display and blood glucose monitoring, thereby improving the user experience.

[0036] Details of one or more embodiments of the present application are set forth in the following drawings and description to make other features, objects, and advantages of the present application more readily apparent. BRIEF DESCRIPTION OF THE DRAWINGS

[0037] The drawings described herein are used to provide a further understanding of the present application and constitute a part of the present application. The illustrative embodiments of the present application and their descriptions are used to explain the present application and do not constitute an improper limitation on the present application. In the drawings:

[0038] Figure 1 is a schematic diagram of the structure of the insulin infusion management device of this embodiment;

[0039] Figure 2 This is a schematic diagram of the interface of the insulin infusion management device of this embodiment;

[0040] Figure 3 is a schematic diagram of the information statistics display area of ​​this embodiment;

[0041] Figure 4 It is a structural schematic diagram of the high-dose estimation interface of this embodiment;

[0042] Figure 5 is a structural schematic diagram of the insulin infusion management system of this embodiment;

[0043] Figure 6 is a schematic structural diagram of an insulin infusion device according to this embodiment;

[0044] Figure 7 Flow chart of the insulin infusion management method of this embodiment. DETAILED DESCRIPTION

[0045] In order to more clearly understand the purpose, technical solutions and advantages of the present application, the present application is described and illustrated below in conjunction with the accompanying drawings and embodiments.

[0046] Unless otherwise defined, the technical terms or scientific terms involved in this application shall have the general meaning understood by people with general skills in the technical field to which this application belongs. The words "one", "a", "the", "these" and the like in this application do not indicate a quantitative limitation, and they may be singular or plural. The terms "include", "comprise", "have" and any variants thereof involved in this application are intended to cover non-exclusive inclusions; for example, a process, method and system, product or device comprising a series of steps or modules (units) is not limited to the listed steps or modules (units), but may include unlisted steps or modules (units), or may include other steps or modules (units) inherent to these processes, methods, products or devices. The words "connect", "connected", "coupled" and the like involved in this application are not limited to physical or mechanical connections, but may include electrical connections, whether direct or indirect. The "multiple" involved in this application refers to two or more. "And / or" describes the association relationship of associated objects, indicating that there may be three relationships, for example, "A and / or B" may mean: A exists alone, A and B exist at the same time, and B exists alone. Generally, the character " / " indicates that the objects associated with each other are in an "or" relationship. The terms "first", "second", "third", etc. in this application are only used to distinguish similar objects and do not represent a specific ordering of the objects.

[0047] In this embodiment, an insulin infusion management device is provided. Figure 1 is a schematic diagram of the structure of the insulin infusion management device of this embodiment; Figure 2 This is a schematic diagram of the interface of the insulin infusion management device of this embodiment; Figure 3 FIG. 1 is a schematic diagram of the information statistics display area of ​​this embodiment. Figure 1As shown, the insulin infusion management device includes a communication module 11 and a user interface 12. The communication module 11 is used to receive blood glucose monitoring information and insulin infusion information carrying time information; the user interface 12 includes a real-time monitoring interface; the real-time monitoring interface includes an information statistics display area 121; the horizontal axis of the information statistics display area 121 is set as a time axis 1211, the first vertical axis 1213 is an insulin infusion dose reference value, and the second vertical axis 1214 is a blood glucose reference value; the time information is mapped on the time axis to form a first association relationship; the information statistics display area 121 displays a blood glucose change curve 1212 generated according to the blood glucose monitoring information and the first association relationship; the blood glucose change curve 1212 includes a plurality of blood glucose level recording points, wherein When a blood glucose level recording point is selected by the first user input, the information statistics display area 121 is controlled to floatly display the numerical display area 1218, and the numerical display area 1218 is vertically connected to the selected blood glucose level recording point through a dotted indicator line, so that the numerical display area 1218 and the blood glucose change curve 1212 are fully displayed in the information statistics display area 121 at the same time; the numerical display area 1218 is also used to receive a drag operation input by a second user, and dynamically select a blood glucose level recording point through a drag operation. The numerical display area 1218 is also used to display corresponding blood glucose monitoring information and / or insulin infusion information according to the dynamically selected blood glucose level recording point.

[0048] Specifically, the above-mentioned insulin infusion management device can be any portable electronic device, such as a smart phone, a smart watch, and a handheld device. Among them, the function of receiving the above-mentioned blood glucose monitoring information and insulin infusion information, and the function of displaying the corresponding user interface 12 can be provided by loading and running the corresponding application in the electronic device. The above-mentioned communication module 11 can be a wireless communication module, such as a communication module implemented based on wireless communication technologies such as Bluetooth and Zigbee. In addition, the above-mentioned communication module 11 can also be a wired communication module, for example, it can be connected to a blood glucose monitoring device and an insulin infusion device based on USB. This embodiment does not specifically limit this.

[0049] Taking wireless communication as an example, the two parties involved in wireless communication are the insulin infusion management device and the blood glucose monitoring device, and / or the insulin infusion management device and the insulin infusion device. Each communication is initiated by the insulin infusion management device and a wireless connection is established. After the wireless connection is established, the insulin infusion management device can actively send a communication request to the insulin infusion device and the blood glucose monitoring device, and the insulin infusion device and the blood glucose monitoring device can respond to the communication request. During the communication process, the insulin infusion management device sends and receives data with the insulin infusion device and the blood glucose monitoring device in the form of communication messages.

[0050] More specifically, the insulin infusion management device communicates with the associated blood glucose monitoring device and the insulin infusion management device through the communication module 11. After receiving the blood glucose monitoring information through the communication module 11, the received blood glucose monitoring information is plotted as a blood glucose change curve 1212 in the information statistics display area 121; in addition, after receiving the insulin infusion information through the communication module 11, the received insulin infusion information is plotted as a bar chart of the infusion information in the information statistics display area 121.

[0051] Based on this, the second vertical axis 1214 corresponding to the blood sugar change curve 1212 can be drawn on one side of the information statistics display area 121, for example, on the left side, to represent the blood sugar concentration, and the unit can be millimoles per liter (mmol / L). The vertical axis range can be set according to the actual application scenario, for example, 0mmol / L to 15mmol / L. The vertical axis of the blood sugar change curve 1212 is evenly distributed from bottom to top. In particular, in some embodiments thereof, the parts of the blood sugar change curve 1212 in different blood sugar value ranges can be represented by different colors. For example, when the blood sugar value is lower than the low blood sugar standard value (for example, 3.9mmol / L), the corresponding curve segment of the blood sugar change curve is displayed in red, when the blood sugar value is higher than the high blood sugar standard value (for example, 10.0mmol / L), the corresponding curve segment of the blood sugar change curve is displayed in yellow, and when the blood sugar value is in the blood sugar safety threshold range, the corresponding curve segment of the blood sugar change curve is displayed in green. The blood glucose change curve 1212 may be composed of a series of discrete points representing the blood glucose values ​​at corresponding moments, such as a curve formed by connecting a series of discrete points, or may be represented as a set of points distributed on a time axis composed of a series of discrete points. The blood glucose change curve 1212 is used to intuitively present the blood glucose levels in the past and current time periods to the user.

[0052] In addition, a numerical display area 1218 may appear through first user input, such as touching and holding or sliding the blood glucose level recording point in the information statistics display area 121, and when the numerical display area 1218 is dragged to a different blood glucose level recording point on the blood glucose change curve, the blood glucose monitoring information and / or insulin infusion information corresponding to that moment may be displayed floatingly in the numerical display area 1218, and the display may last for a certain period of time before disappearing, such as lasting for 1 second, 2 seconds, or 5 seconds before disappearing.

[0053] The first vertical axis 1213 may be drawn on the other side of the information statistics display area 121, such as the right side, to represent the infusion dose, and the first vertical axis 1213 may also be evenly distributed from top to bottom. The time range of the time axis 1211 is adjustable.

[0054] When a drag operation of the second user input to the numerical display area 1218 is received, the blood glucose level recording point is dynamically selected through the drag operation, and the blood glucose monitoring information and / or insulin infusion information are displayed in association in the numerical display area 1218 according to the dynamically selected blood glucose level recording point. It can be understood that in some embodiments, the blood glucose monitoring information, insulin infusion information and time can be displayed together. In particular, based on Figure 2 It can be seen that in some embodiments, the basal rates set at different times may be different, so that a basal rate bar graph with high and low changes is presented on the real-time monitoring interface.

[0055] Optionally, in response to the first user input, a numerical display area 1218 can be displayed floatingly in the information statistics display area 121, so that the numerical display area 1218 is vertically connected to the selected blood glucose level recording point through a dotted indicator line, thereby clearly indicating the correlation between the specific numerical content presented in the numerical display area 1218 and the specific blood glucose level recording point on the blood glucose change curve, while avoiding obstruction of the blood glucose change curve in the numerical display area 1218.

[0056] This embodiment can clearly and completely present the blood sugar change curve and the floating displayed numerical information on the real-time monitoring interface, so that the user can accurately and comprehensively know the blood sugar monitoring information and / or insulin infusion information corresponding to the current moment, as well as the complete blood sugar change situation and insulin infusion change situation within a period of time.

[0057] Additionally, after receiving the first user input, the insulin infusion management device will read the blood sugar level recording point selected by the first user input from a plurality of blood sugar level recording points, and obtain the pre-recorded blood sugar monitoring information and / or insulin infusion information corresponding to the time corresponding to the blood sugar level recording point. Afterwards, the blood sugar monitoring information and / or insulin infusion information are filled in the numerical display area 1218 together. In addition, after reading the blood sugar monitoring information and insulin infusion information corresponding to the blood sugar level recording point, the read value can also be compared with the preset corresponding threshold value to determine whether the blood sugar monitoring information and insulin infusion information of the blood sugar level recording point are within the normal range. Afterwards, a prompt indicating whether the corresponding numerical value is normal or abnormal can also be given in the numerical display area 1218.

[0058] This embodiment provides a floating display function in the information statistics display area 121. Based on the interaction with the user, the blood glucose monitoring information and / or insulin infusion information of the recording point specified by the user is displayed in a floating manner without blocking the blood glucose change curve. The blood glucose monitoring information and insulin infusion information corresponding to a single time point of interest to the user and the overall blood glucose change and insulin infusion change within a certain period of time can be presented to the user at the same time, providing the user with a flexible and accurate way to trace back the specific blood glucose monitoring information and insulin infusion information at each time point. In addition, this embodiment can achieve full interaction with the user, present the blood glucose monitoring information and insulin infusion information of interest to the user based on the user input, thereby achieving a richer user experience and improving the user experience of the infusion interface in insulin infusion management and blood glucose monitoring.

[0059] It should also be noted that the present embodiment provides more user interaction methods, such as dynamic dragging and pressing floating display, which, combined with interface graphic elements, can bring more operating experience to users. Compared with the interface display method that only uses graphics or text, the insulin infusion management device provided in this embodiment can meet the user's usage needs in different scenarios.

[0060] The insulin management device provided in this embodiment obtains the patient's insulin infusion information and blood glucose monitoring information through wireless communication with the insulin infusion device and the continuous blood glucose monitoring device, and displays the insulin infusion information and blood glucose monitoring information on the user interface, thereby ensuring the safety and reliability of insulin infusion control and blood glucose monitoring and improving the user experience. Furthermore, this embodiment can provide users with more comprehensive and sufficient blood glucose monitoring information by integrating multi-dimensional blood glucose monitoring information and mixing the display of closed-loop blood glucose monitoring information and insulin infusion information in a time-corresponding manner in the same display area, monitoring blood glucose changes from multiple dimensions, improving the convenience of blood glucose monitoring and blood glucose control, so that insulin infusion control, infusion display and blood glucose monitoring can be performed simultaneously, thereby improving the user experience.

[0061] In one embodiment, the information statistics display area 121 is also used to display a blood glucose safety block 1219; the upper boundary of the blood glucose safety block 1219 corresponds to the upper limit value of the preset blood glucose safety threshold range; the lower boundary of the blood glucose safety block 1219 corresponds to the lower limit value of the preset blood glucose safety threshold range; the blood glucose safety block 1219 is used to monitor the changing trend of the blood glucose change curve 1212, wherein the part of the blood glucose change curve 1212 that exceeds the blood glucose safety block 1219 forms an alarm curve, and the display method of the alarm curve is different from the display method of the blood glucose change curve 1212.

[0062] Specifically, the blood sugar safety block 1219 can be displayed as a background graphic below the blood sugar change curve 1212, and the blood sugar change curve 1212 can be superimposed on the blood sugar safety block 1219. The blood sugar safety threshold range can be a threshold range under normal blood sugar conditions set based on medical standards.

[0063] The alarm curve can be displayed in a color that is different from the blood glucose change curve 1212 within the blood glucose safety threshold range. Exemplarily, when the blood glucose change curve is lower than the lower limit of the blood glucose safety threshold range (e.g., 3.9 mmol / L), the corresponding curve segment of the blood glucose change curve can be displayed in red to form an alarm curve; when the blood glucose value is higher than the upper limit of the blood glucose safety threshold range (e.g., 10.0 mmol / L), the corresponding curve segment of the blood glucose change curve is displayed in yellow to form an alarm curve. When the blood glucose value is within the blood glucose safety threshold range, the corresponding curve segment of the blood glucose change curve is displayed in green.

[0064] By displaying the blood sugar safety block 1219 in the information statistics display area 121, this embodiment can more clearly indicate whether the change in blood sugar value exceeds the blood sugar safety threshold range in data presentation by comparing with the blood sugar change curve 1212, thereby facilitating users to understand their own blood sugar status more timely and clearly.

[0065] In one embodiment, the user interface 12 also includes a large-dose infusion setting interface, which is used to set a single large-dose infusion information or multiple large-dose infusion information at the same time in response to a third user input; the information statistics display area 121 is also used to display a first bar graph 1220, and the first bar graph 1220 includes a first monochrome block and a first multi-color combination block. The first monochrome block is used to represent the single large-dose numerical information; the first multi-color combination block is used to represent multiple large-dose infusion information at the same time.

[0066] The bolus infusion information can be displayed in the form of a bar graph on the information statistics display area 121. The vertical axis on one side of the information statistics display area 121 represents the bolus infusion dosage, and the insulin infusion information over a period of time is displayed in the form of a chart. It can be understood that the first bar graph 1220 will change with the update of the insulin infusion information, and the user is presented with the change of the bolus infusion information in the past and the current time.

[0067] For example, if the user controls the insulin infusion device to perform multiple large-dose infusion control settings at a certain time point, such as 18:00, through the above insulin infusion management device. For example, the first set infusion dose is 8.4U (insulin dosage unit), the second set infusion dose is 2.4U, and the third set infusion dose is 2.4U, then the insulin infusion management device will count the multiple infusions at that time, and the first combination block corresponding to the multiple continuous infusions at the same time will be displayed on the information statistics display area 121. For details, please refer to Figure 3 The upper column, the middle column and the lower column of the first multi-color combination block are displayed in different colors or textures, and the text description of the dose of multiple continuous infusions is displayed above the graph. When the user sets a single large dose of insulin infusion at a certain time point, it is displayed in the first monochrome block on the information statistics display area 121, for example Figure 2 The first monochrome block in .

[0068] This embodiment displays multiple large-dose insulin infusions set at the same time in a combined form in the first bar chart, and displays single large-dose infusion information in monochrome blocks. This can record single large-dose infusions and multiple large-dose infusions, and clearly, concisely, accurately and intuitively present the infusion information in the continuous large-dose infusion scenario, which is convenient for users to more clearly and comprehensively control the large-dose infusion information and improve the user experience.

[0069] In addition, in one embodiment, the user interface 12 also includes a basal rate infusion setting interface, which is used to set regular basal rate infusion information or temporary basal rate infusion information at different times in response to a fourth user input; the information statistics display area 121 also includes a second bar graph 1222, and the second bar graph 1222 is used to display regular basal rate information or temporary basal rate numerical information at different times; wherein, the first bar graph 1220 and the second bar graph 1222 have a partially overlapping area, and the first bar graph 1220 and the second bar graph 1222 are displayed separately.

[0070] Among them, Figure 2 As shown, the column in the first bar graph 1220 can be a long column. The second bar graph and the first bar graph 1220 can be distinguished and displayed by different colors or textures. The second bar graph 1222 can also calibrate the dose based on the first vertical axis 1213. In this embodiment, the two different infusion types, large-dose infusion and basal rate infusion, are distinguished and displayed by different bar graphs, so that more sufficient and comprehensive infusion information can be presented in the same display area, providing convenience for users to control different types of insulin infusion.

[0071] In particular, in one embodiment, the user interface 12 further includes an event record interface; the event record interface is used to record the event time and event behavior corresponding to the blood glucose monitoring management in response to the fifth user input; the information statistics display area 121 is also used to display the event identifier 1221. For details, please refer to Figure 3 , the event identifier 1221 is arranged corresponding to the time axis 1211.

[0072] In some of the embodiments, the event time and event behavior can be recorded by clicking the record button in the event recording interface, and the event recording interface will display each event according to the date. After the user selects a recorded event in the event recording interface, the corresponding event can be deleted by clicking the delete button. Clicking the date button can select the corresponding event recording date. Exemplarily, the user can record events such as injection events (such as "14:53 injection premix 1U"), medication events (such as "14:02 cold medicine aciparum"), meal events (such as "13:40 meal 50.0g"), postprandial blood sugar change events (such as "13:40 lunch after 10.0mmol / L"), exercise events (such as "11:38 indoor running for 3 hours"), etc. The graphic content and background color in the event identifier of different events are different.

[0073] That is, when the user eats, including breakfast, lunch, dinner and snacks, exercises or other events, the corresponding events can be recorded through the event recording interface. Figure 3 As shown, the information statistics display area 121 will arrange and display the corresponding event identifiers 1221 at the corresponding moments of the time axis 1211, and the event identifiers 1221 may present different patterns according to the specific event types. The user can intuitively understand the events such as meals and exercises that occurred within the specified time period based on the various event identifiers 1221 on the information statistics display area 121. It should also be noted that since the insulin infusion device is continuously infusing insulin, the infusion information on the information statistics display area 121 will be continuously updated, and the event identifiers 1221 will also move with the update of the time on the time axis 1211. When the time of the event exceeds the time period displayed on the time axis 1211, the event identifier will disappear.

[0074] When there are multiple event identifiers, based on the corresponding event identifier information, different event identifiers are arranged above the corresponding time of the time axis 1211. In particular, when multiple events occur at the same time, multiple event identifiers can be arranged from bottom to top at the same time according to the order of entry.

[0075] In this embodiment, by providing the user with an interface for recording events related to blood glucose monitoring management and displaying relevant event identifiers input by the user, blood glucose related information can be presented in a more multi-dimensional manner. In addition, by arranging and displaying event identifiers based on time information, the correlation between events corresponding to blood glucose monitoring management and changes in blood glucose levels can be presented to the user more accurately.

[0076] Additionally, in one embodiment, the information statistics display area 121 displays at least one time label 1225; the time label 1225 corresponds to a time segment on the display timeline 1211; the information statistics display area 121 is also used to respond to a first user input to select a time label 1225, and to display the corresponding time segment on the timeline 1211 according to the switching of the selected time label 1225, as well as the corresponding blood glucose change curve 1212 and event identifier 1221 within the displayed time segment.

[0077] By setting different time labels 1225, users can be provided with a variety of time display range options, so that users can view blood sugar changes in different time periods, events related to blood sugar monitoring management, and insulin infusion conditions based on their own needs, thereby further improving the user experience.

[0078] In one embodiment, the real-time monitoring interface also includes a real-time blood glucose display area 1226; the real-time blood glucose display area 1226 is used to display the current blood glucose monitoring information monitored in real time, and to generate a blood glucose abnormality prompt when the current blood glucose monitoring information exceeds the blood glucose safety threshold range.

[0079] The real-time blood glucose display area 1226 can display the latest blood glucose monitoring information and display the blood glucose values ​​in different blood glucose states in different colors. At the same time, the blood glucose change trend can be indicated by arrows of different colors, different values, and different directions. The blood glucose value and the blood glucose trend indicator arrow are both set in the real-time blood glucose display area 1226, and the user can intuitively understand the current blood glucose monitoring information status and blood glucose change trend at the same time. For example Figure 2 In the display, when the user's blood sugar has no tendency to increase or decrease, a horizontal rightward arrow can be displayed next to the reading; when the user's blood sugar increases, an upward arrow can be displayed next to the reading. When the user's blood sugar decreases, a downward arrow will be displayed next to the reading in the real-time blood sugar display area 1226. If the current blood sugar value is lower than the lower limit of the blood sugar safety threshold range, the color of the reading will be changed, for example, the reading will be displayed in red, thereby forming an abnormal blood sugar prompt. It can also be understood that abnormal blood sugar prompts can also be generated in other forms, such as directly outputting text of abnormal blood sugar, or an image representing abnormal blood sugar, or flashing, etc.

[0080] Based on this, users can understand the current blood sugar status and change trend at the same time through the real-time blood sugar display area, and can also promptly understand the abnormal blood sugar status and take corresponding measures to change the status of the insulin infusion device.

[0081] In some of the embodiments, the real-time monitoring interface further includes an insulin infusion display area 1227; the insulin infusion display area 1227 is used to display basal rate infusion information and bolus infusion information; the bolus infusion information includes the dosage value and infusion time of the most recent bolus infusion.

[0082] Specifically, the insulin infusion display area 1227 displays basal rate numerical information, such as displaying basal rate B1 "0.900 U / h", displaying the dosage value of the last large dose infusion such as "6.0 U", and the last large dose infusion time "08-26 12:30" and the like.

[0083] This embodiment can facilitate the user to clearly understand the current insulin infusion type and infusion situation by displaying the current insulin infusion status on the real-time monitoring interface.

[0084] Additionally, in some of the embodiments, the real-time monitoring interface further includes a device information display area 1228; the device information display area 1228 is used to display the remaining usage time of the associated blood glucose monitoring device.

[0085] For example, the blood glucose monitoring device may be a continuous glucose monitoring (CGM) sensor, which can communicate with the CGM sensor to obtain and display the remaining usage time of the CGM sensor, such as prompting "11.1 days remaining". The CGM sensor has a timer set inside, which is usually associated with the working life of the CGM sensor and can display the remaining usage time on the supporting software or device.

[0086] This embodiment can provide the user with a clear and accurate device usage status by displaying the remaining usage time of the blood glucose monitoring device, thereby facilitating the user to perform maintenance on the blood glucose monitoring device in a timely manner.

[0087] In particular, in some embodiments, the device information display area 1228 can also prompt the unavailable state of the device. When the blood glucose monitoring device is disconnected from the insulin infusion management device, or the blood glucose monitoring device fails, etc., the device information display area 1228 of the user interface prompts with a text description of "Currently not connected to CGM", and in the real-time blood glucose display area 1226, a short horizontal line "--" or the like prompts that the current blood glucose monitoring information has not been read. It can be understood that the insulin infusion management device can also form prompts in other graphic or text forms, and this embodiment does not specifically limit this.

[0088] In addition, in some embodiments, the real-time monitoring interface further includes an active insulin display area 1229, which is used to indicate the infusion dose of insulin currently taking effect.

[0089] In addition, in some embodiments, the real-time monitoring interface also includes a first details button 1230. After the user clicks the first details button 1230, the real-time monitoring interface will pop up a first prompt box containing the status information of the associated blood glucose monitoring device, the status information of the insulin infusion device, and the total amount of insulin and the average blood glucose in a certain time period. Alternatively, when the user clicks the first details button 1230 in the upper right corner of the real-time monitoring interface, a first prompt box will pop up above the real-time monitoring interface, which contains: CGM brand name, serial number, connection status, remaining days, activation time, time from the last calibration, etc. Therefore, the user can quickly learn about the blood glucose status, insulin infusion status and associated device status within a preset time period through the first prompt box.

[0090] In particular, in one embodiment, the real-time monitoring interface further includes a control mode display area 1232, which is used to indicate whether the current control of the insulin infusion device is in manual mode or automatic mode. When the control mode display area 1232 displays manual mode, the infusion control of the insulin infusion device is manually controlled by the user, and when the control mode display area 1232 displays automatic mode, the infusion control of the insulin infusion device is automatically based on the control of the insulin infusion management device.

[0091] In addition, the real-time monitoring interface also includes a communication icon 1233 for indicating a communication connection with the blood glucose monitoring device. Additionally, the real-time monitoring interface may also include an alarm icon for displaying alarms of different priorities.

[0092] In some embodiments, Figure 3As shown, the above-mentioned real-time monitoring interface can also set a second details button 1235 in the information statistics display area 121. When the user clicks the second details button 1235, a second prompt box will pop up above the real-time monitoring interface, which contains: the remaining amount of medicine, the remaining power, the duration of the pump connection, the connection status of the CGM, the target blood glucose value, the total amount of insulin today, the total amount of insulin yesterday, the average blood glucose today, the average blood glucose yesterday and other information. As a result, the user can quickly learn about the blood glucose situation, insulin infusion situation and the status of the associated equipment within the preset time period through the second prompt box. In addition, the real-time monitoring interface can also be provided with a zoom button 1236. The user clicks the zoom button 1236 to zoom in and view the information statistics display area 121, and obtains an enlarged view of the horizontal display area, so that the user can view the information statistics display area more clearly.

[0093] Figure 4 FIG. 1 is a schematic diagram of the structure of the high-dose estimation interface of this embodiment. In one embodiment, the user interface 12 also includes the following Figure 4 The large dose estimation interface shown in the figure includes a blood glucose value setting area 131; the blood glucose value setting area 131 is used to display a first option 1311 and a second option 1312; the first option 1311 is used to select a dynamic continuous blood glucose monitoring value as the current blood glucose monitoring information; the second option 1312 is used to select the current finger blood value as the current blood glucose monitoring information; the blood glucose value setting area 131 is also used to respond to the selection operation of the first option 1311 by the sixth user input, use the dynamic continuous blood glucose monitoring value as the current blood glucose monitoring information, and set the second option 1312 to not respond to the user input operation; and, in response to the selection operation of the second option 1312 by the seventh user input, use the received current finger blood value as the current blood glucose monitoring information. It can be understood that the large dose estimation interface can include more areas, which are not limited here.

[0094] After the user selects the first option 1311, the second option 1312 will be grayed out, and the current blood glucose value will be set according to the dynamic continuous blood glucose monitoring value. When the user selects the second option 1312, the finger blood value with higher blood glucose monitoring accuracy can be used as the current blood glucose value. Among them, the current finger blood value can be transmitted by the finger blood collection device or input by the user according to the finger blood test result. In this embodiment, two ways of determining the current blood glucose value are provided for the user, which can facilitate the user to select more convenient and accurate blood glucose data as the current blood glucose value according to the actual situation, thereby improving the flexibility of obtaining the current blood glucose value and enhancing the user experience.

[0095] In one embodiment, the user interface 12 also includes a statistical analysis interface; the statistical analysis interface includes a blood glucose statistics area, a blood glucose overview area and an injection overview area; the blood glucose statistics area is used to respond to the user's selection of a statistical date, and count and display the blood glucose change statistics chart, large-dose infusion statistics chart and basal rate infusion statistics chart corresponding to the corresponding statistical date; the blood glucose overview area is used to respond to the user's selection of a statistical date, and count and display the multi-dimensional blood glucose status quantitative indicators of the corresponding statistical date; the injection overview area is used to respond to the user's selection of a statistical date, and count and display the total amount of insulin, the total amount of large doses, the total amount of basal rate and the total amount of carbohydrates on the corresponding statistical date.

[0096] The statistical analysis interface provided in this embodiment can output blood sugar statistical information of the corresponding date to the user based on the selection of the statistical date by the user, including the blood sugar overview area of ​​the time within the glucose target range TIR, the time when the glucose concentration is lower than the target range TBR, the time when the glucose concentration is higher than the target range TAR, and the average blood sugar MG, as well as the statistical information including the total amount of insulin, the total amount of large doses, the total amount of basal rate, and the total amount of carbohydrates. In particular, in one embodiment, the statistical analysis interface is also used to generate a dynamic glucose map in response to the twelfth user input.

[0097] In particular, in some embodiments, the statistical analysis interface may include a function for performing statistical analysis on the changes in algorithm parameters and the switching of modes. The statistical analysis interface includes a tab bar, a statistical information display area, a statistical date button, and an information sending button. Among them, the user can switch to the "temporary basis", "mode switching", "nursing", "algorithm parameters" and "all" tabs through the tab bar to view the corresponding statistical information. For example, the "temporary basis" tab can display statistical information related to the setting and change of the temporary basal rate, the "mode switching" tab can display the switching information of switching the insulin infusion device to the above-mentioned "manual mode" or "automatic mode", the "nursing" tab can display the injection and reset information of the insulin infusion device, the "algorithm parameters" tab displays the relevant information on the changes in the algorithm parameters, and the "all" tab displays the statistical information corresponding to the above-mentioned "temporary basis", "mode switching", "nursing" and "algorithm parameters" tabs.

[0098] The statistical information display area can display corresponding statistical information by date; the statistical date button can switch to display statistical information corresponding to different dates; the user can send the statistical information by clicking the information sending button, for example, to other mobile terminals associated with the user.

[0099] In this embodiment, by performing statistical analysis on blood sugar change information, insulin infusion information, associated device status and other information, users can understand the overview information of insulin infusion control, thereby improving the efficiency of insulin infusion management and control for users.

[0100] Optionally, in one embodiment, the user can customize the display of each area module in the real-time monitoring interface. The real-time monitoring interface can be divided into several operable area modules, and a monitoring event is associated with each area module. When it is monitored that the user long presses a certain area module, the area module is set to be hidden or displayed, and the position layout of different area modules is modified.

[0101] Optionally, in one embodiment, users of different insulin value management devices can follow each other. The user follow list interface includes an operation bar, a tab bar, and a follow list area. Among them, the user can add a new follower by clicking the add button in the operation bar, click the prompt button in the operation bar to display the follow prompt of the follow list, and click the message button to display the corresponding follower message. The user selects the "All", "I'm Following", "Follow Me" tabs in the tab bar, and different user lists are displayed in the follow list area accordingly. The follow list area can display the user name, user contact information, and the user's blood sugar health status and ranking.

[0102] After becoming a follower of a certain user, you can click on the details page of the person being followed from your own follow list interface to view the corresponding diagnosis and treatment information. This embodiment can facilitate medical staff or family members to remotely monitor patients by setting up a user follow list interface. All the people being followed are displayed in the follower list. They are automatically ranked from top to bottom according to the level of treatment effect TIR. In addition, you can also like and send private messages to other users.

[0103] In this embodiment, an insulin infusion management system is provided. Figure 5 FIG. 1 is a schematic diagram of the structure of the insulin infusion management system of this embodiment. Figure 5 As shown, the insulin infusion management system includes: a blood glucose monitoring device 52, an insulin infusion device 54, and an insulin infusion management device 56 provided by any of the above embodiments; wherein: the blood glucose monitoring device 52 is used to perform blood glucose monitoring to obtain blood glucose monitoring information; the insulin infusion management device 56 is used to receive and display blood glucose monitoring information and insulin infusion information, and generate infusion instructions based on the blood glucose monitoring information and insulin infusion information; the insulin infusion device 54 is used to receive infusion instructions to perform insulin infusion.

[0104] The insulin infusion management device 56 is respectively connected to the blood glucose monitoring device 52 and the insulin infusion device 54 in communication. The blood glucose monitoring device 52 may be a CGM. The insulin infusion device may be an insulin pump. The blood glucose monitoring device 52 and the insulin infusion device 54 may be integrated or separated, which is not specifically limited in this embodiment.

[0105] Figure 6 FIG. 5 is a schematic diagram of the structure of an insulin infusion device 54 of this embodiment. Figure 6 As shown, the insulin infusion device 54 includes: a battery compartment 541, a reservoir adapter 542, a reservoir chamber 543 and a touch screen 544. When in use, the insertion mechanism of the insulin infusion device 54 is inserted under the human skin, and the other parts of the insulin infusion device 54 are attached to the surface of the human skin. The insulin infusion management device 56 controls the insulin infusion device 54 to achieve insulin infusion to the human body based on communication with the insulin infusion device 54.

[0106] Exemplarily, in some of the embodiments, the communication between the insulin infusion management device 56 and the insulin infusion device 54 may include the following device binding pairing process: after the insulin infusion management device 56 sends an initiation request for pairing or unpairing to the insulin infusion device 54, the insulin infusion device 54 sends an initiation response for pairing or unpairing to the insulin infusion management device 56, and the initiation response includes a binding feature code that is randomly generated in the current state and is not all zero; when the insulin infusion management device 56 and the insulin infusion device 54 perform pairing or unpairing confirmation, the insulin infusion device 54 first receives the pairing or unpairing confirmation request sent by the insulin infusion management device 56, and then determines whether the binding feature code in the confirmation request is the binding feature code included in the initiation response. If so, it confirms that the pairing or unpairing operation is successful, otherwise it confirms that the pairing or unpairing operation fails.

[0107] The above-mentioned insulin infusion management system can provide users with more comprehensive and sufficient blood sugar monitoring information, monitor blood sugar changes from multiple dimensions, improve the convenience of blood sugar monitoring and display for blood sugar control, and thus can simultaneously perform insulin infusion control, infusion display and blood sugar monitoring, thereby improving the user experience.

[0108] In this embodiment, an insulin infusion control method is also provided, which is used in the insulin infusion management device provided in the above embodiment; Figure 7 is a flow chart of the insulin infusion management method of this embodiment, as shown in Figure 7 As shown, the insulin infusion management method comprises the following steps:

[0109] Step S701, receiving blood glucose monitoring information and insulin infusion information carrying time information;

[0110] Step S702, displaying a real-time monitoring interface, the real-time monitoring interface including an information statistics display area;

[0111] Step S703, setting the horizontal axis of the information statistics display area to be the time axis, the first vertical axis to be the insulin infusion dose reference value, and the second vertical axis to be the blood glucose reference value; the time information is mapped on the time axis to form a first association relationship;

[0112] Step S704, controlling the information statistics display area to display a blood glucose change curve generated according to the blood glucose monitoring information and the first association relationship; the blood glucose change curve includes a plurality of blood glucose level recording points, wherein when a blood glucose level recording point is selected by the first user input, controlling the information statistics display area to floatly display a numerical display area, and the numerical display area is vertically connected to the selected blood glucose level recording point through a dotted indicator line, so that the numerical display area and the blood glucose change curve are fully displayed simultaneously in the information statistics display area;

[0113] Step S705, receiving a drag operation input by a second user, dynamically selecting a blood glucose level recording point through the drag operation, and the numerical display area is also used to display corresponding blood glucose monitoring information and / or insulin infusion information in association with the dynamically selected blood glucose level recording point.

[0114] In the above steps S701 to S705, the patient's insulin infusion information and blood glucose monitoring information are obtained through wireless communication with the insulin infusion device and the continuous blood glucose monitoring device, and the insulin infusion information and blood glucose monitoring information are displayed on the user interface to ensure the safety and reliability of insulin infusion control and blood glucose monitoring, thereby improving the user experience. Furthermore, this embodiment can provide users with more comprehensive and sufficient blood glucose monitoring information by integrating multi-dimensional blood glucose monitoring information and mixing the display of closed-loop blood glucose monitoring information and insulin infusion information in a time-corresponding manner in the same display area, monitoring blood glucose changes from multiple dimensions, improving the convenience of blood glucose monitoring and blood glucose control, so that insulin infusion control, infusion display and blood glucose monitoring can be performed simultaneously, thereby improving the user experience.

[0115] It can be understood that the specific examples of the insulin infusion management method in this embodiment can also refer to the examples described in the above-mentioned embodiments and optional implementations of the insulin infusion management device, and will not be repeated in this embodiment.

[0116] It should be understood that the specific embodiments described herein are only used to explain the application, rather than to limit it. Based on the embodiments provided in this application, all other embodiments obtained by ordinary technicians in this field without creative work are within the protection scope of this application.

[0117] It should be noted that the user information (including but not limited to user device information, user personal information, etc.) and data (including but not limited to data used for analysis, stored data, displayed data, etc.) involved in this application are all information and data authorized by the user or fully authorized by all parties.

[0118] Obviously, the drawings are only some examples or embodiments of the present application. For ordinary technicians in the field, the present application can also be applied to other similar situations based on these drawings without creative work. In addition, it is understandable that although the work done in this development process may be complicated and lengthy, for ordinary technicians in the field, certain changes in design, manufacturing or production based on the technical content disclosed in this application are only conventional technical means and should not be regarded as insufficient content disclosed in this application.

[0119] The term "embodiment" in this application refers to a specific feature, structure or characteristic described in conjunction with the embodiment that can be included in at least one embodiment of the present application. The appearance of this phrase in various locations in the specification does not necessarily mean the same embodiment, nor does it mean that it is mutually exclusive with other embodiments and is independent or optional. It is clearly or implicitly understood by those of ordinary skill in the art that the embodiments described in this application can be combined with other embodiments without conflict.

[0120] The above-mentioned embodiments only express several implementation methods of the present application, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of patent protection. It should be pointed out that, for a person of ordinary skill in the art, several variations and improvements can be made without departing from the concept of the present application, and these all belong to the scope of protection of the present application. Therefore, the scope of protection of the present application shall be subject to the attached claims.

Claims

1. An insulin infusion management device, characterized in that: include: A communication module (11) and a user interface (12); wherein: the communication module (11) is used to receive blood sugar monitoring information and insulin infusion information carrying time information; The user interface (12) includes a real-time monitoring interface; The real-time monitoring interface comprises an information statistics display area (121); the horizontal axis of the information statistics display area (121) is set as a time axis (1211), the first vertical axis (1213) is an insulin infusion dose reference value, and the second vertical axis (1214) is a blood glucose reference value; the time information is mapped on the time axis (1211) to form a first association relationship; The information statistics display area (121) displays a blood sugar change curve (1212) generated according to the blood sugar monitoring information and the first association relationship; the blood sugar change curve (1212) includes a plurality of blood sugar level recording points, wherein when the blood sugar level recording point is selected by a first user input, the information statistics display area (121) is controlled to float display a numerical display area (1218), and the numerical display area (1218) is vertically connected to the selected blood sugar level recording point through a dotted indicator line, so that the numerical display area (1218) and the blood sugar change curve (1212) are fully displayed simultaneously in the information statistics display area (121); The numerical display area (1218) is also used to receive a drag operation input by a second user, and dynamically select a blood glucose level recording point through the drag operation. The numerical display area (1218) is also used to display corresponding blood glucose monitoring information and / or insulin infusion information based on the dynamically selected blood glucose level recording point.

2. The insulin infusion management device according to claim 1, characterized in that: The information statistics display area (121) is also used to display a blood sugar safety block (1219); The upper boundary of the blood sugar safety block (1219) corresponds to the upper limit value of the preset blood sugar safety threshold range; the lower boundary of the blood sugar safety block (1219) corresponds to the lower limit value of the preset blood sugar safety threshold range; The blood sugar safety block (1219) is used to monitor the changing trend of the blood sugar change curve (1212), wherein the portion of the blood sugar change curve (1212) that exceeds the blood sugar safety block (1219) forms an alarm curve, and the display method of the alarm curve is different from the display method of the blood sugar change curve (1212).

3. The insulin infusion management device according to claim 1, characterized in that: The user interface (12) further comprises a bolus infusion setting interface, wherein the bolus infusion setting interface is used to set single bolus infusion information or multiple bolus infusion information at the same time in response to a third user input; The information statistics display area (121) is also used to display a first bar graph (1220), wherein the first bar graph (1220) comprises a first monochrome block and a first multi-color combination block, wherein the first monochrome block is used to represent single large-dose numerical information; and the first multi-color combination block is used to represent multiple large-dose infusion information at the same time.

4. The insulin infusion management device according to claim 3, characterized in that: The user interface (12) further comprises a basal rate infusion setting interface, wherein the basal rate infusion setting interface is used to set regular basal rate infusion information or temporary basal rate infusion information at different times in response to a fourth user input; The information statistics display area (121) also includes a second bar graph (1222), which is used to display regular basic rate information or temporary basic rate numerical information at different times; wherein the first bar graph (1220) and the second bar graph (1222) have a partially overlapping area, and the first bar graph (1220) and the second bar graph (1222) are displayed separately.

5. The insulin infusion management device according to claim 4, characterized in that: The user interface (12) also includes an event recording interface; The event recording interface is used to record event time and event behavior corresponding to blood glucose monitoring management in response to a fifth user input; The information statistics display area (121) is also used to display event identification (1221).

6. The insulin infusion management device according to claim 5, characterized in that: The information statistics display area (121) displays at least one time label (1225); the time label (1225) corresponds to a time segment on the display time axis (1211); The information statistics display area (121) is also used to respond to the first user input to select the time label (1225), and switch the display of the corresponding time segment on the time axis (1211) according to the selected time label (1225), as well as the blood sugar change curve (1212) and event identification (1221) within the corresponding displayed time segment.

7. The insulin infusion management device according to claim 6, characterized in that: The real-time monitoring interface also includes a real-time blood glucose display area (1226); the real-time blood glucose display area (1226) is used to display the current blood glucose monitoring information monitored in real time; the real-time blood glucose display area (1226) is also used to generate a blood glucose abnormality prompt when the current blood glucose monitoring information exceeds the blood glucose safety threshold range.

8. The insulin infusion management device according to claim 7, characterized in that: The user interface (12) further comprises a bolus estimation interface; the bolus estimation interface comprises a blood glucose value setting area (131); the blood glucose value setting area (131) is used to display a first option (1311) and a second option (1312); the first option (1311) is used to select a dynamic continuous blood glucose monitoring value as current blood glucose monitoring information; the second option (1312) is used to select a current finger blood value as current blood glucose monitoring information; The blood glucose value setting area (131) is further used to respond to a selection operation of the first option (1311) input by a sixth user, use the dynamic continuous blood glucose monitoring value as current blood glucose monitoring information, and set the second option (1312) to not respond to user input operations; And, in response to the seventh user inputting a selection operation on the second option (1312), the received current finger blood value is used as the current blood sugar monitoring information.

9. An insulin infusion management system, characterized in that: include: A blood glucose monitoring device (52), an insulin infusion device (54), and an insulin infusion management device (56) as claimed in any one of claims 1 to 8; wherein: The blood sugar monitoring device (52) is used to perform blood sugar monitoring to obtain blood sugar monitoring information; The insulin infusion management device (56) is used to receive and display the blood sugar monitoring information and the insulin infusion information, and to generate an infusion instruction according to the blood sugar monitoring information and the insulin infusion information; The insulin infusion device (54) is used to receive the infusion instruction and perform insulin infusion.

10. A method for managing insulin infusion, characterized in that: The method comprises: Receive blood glucose monitoring information and insulin infusion information with time information; Displaying a real-time monitoring interface, the real-time monitoring interface including an information statistics display area; The horizontal axis of the information statistics display area (121) is set as the time axis (1211), the first vertical axis (1213) is the insulin infusion dose reference value, and the second vertical axis (1214) is the blood glucose reference value; the time information is mapped on the time axis (1211) to form a first association relationship; Controlling the information statistics display area (121) to display a blood glucose change curve (1212) generated according to the blood glucose monitoring information and the first association relationship; the blood glucose change curve (1212) includes a plurality of blood glucose level recording points, wherein when the blood glucose level recording point is selected by a first user input, controlling the information statistics display area (121) to display a numerical value display area (1218) in a floating manner, wherein the numerical value display area (1218) is vertically connected to the selected blood glucose level recording point through a dotted indicator line, so that the numerical value display area (1218) and the blood glucose change curve (1212) are fully displayed simultaneously in the information statistics display area (121); A drag operation input by a second user is received, and a blood glucose level recording point is dynamically selected through the drag operation. The numerical display area (1218) is also used to display corresponding blood glucose monitoring information and / or insulin infusion information in association with the dynamically selected blood glucose level recording point.

Images